KARLIN DANIEL (Chief Medical Officer) sold 1.3% of their position (5.60K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $73.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/29/2025ACC: 0001193125-25-335484
Officer· Chief Medical Officer
Since Jan 2022
-5.60K
Net shares
Net seller
$73.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.60K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−5.60K
Price / share
$13.15
Trade value
$73.62K
% of position
1.3%
12/26/2025
430.63K→425.02K
Total
Net shares
−5.60K
Net value
-$73.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 12/26/2025 | S · Sale | −5.60K | $13.15 | $73.62K | 1.3% | 430.63K | 425.02K |
| Total | −5.60K | -$73.62K | ||||||
Derivative Transactions0
No derivative transactions reported